These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 37672017

  • 1. Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review.
    Hysa E, Bond M, Ehlers L, Camellino D, Falzon L, Dejaco C, Buttgereit F, Aletaha D, Kerschbaumer A.
    Rheumatology (Oxford); 2024 Feb 01; 63(2):285-297. PubMed ID: 37672017
    [Abstract] [Full Text] [Related]

  • 2. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
    Hysa E, Casabella A, Gotelli E, Campitiello R, Schenone C, Genova C, Tanda ET, Sulli A, Smith V, Cimmino MA, Paolino S, Cutolo M.
    Autoimmun Rev; 2024 Feb 01; 23(7-8):103589. PubMed ID: 39117006
    [Abstract] [Full Text] [Related]

  • 3. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 4. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
    Dejaco C, Kerschbaumer A, Aletaha D, Bond M, Hysa E, Camellino D, Ehlers L, Abril A, Appenzeller S, Cid MC, Dasgupta B, Duftner C, Grayson PC, Hellmich B, Hočevar A, Kermani TA, Matteson EL, Mollan SP, Neill L, Ponte C, Salvarani C, Sattui SE, Schmidt WA, Seo P, Smolen JS, Thiel J, Toro-Gutiérrez CE, Whitlock M, Buttgereit F.
    Ann Rheum Dis; 2024 Jan 02; 83(1):48-57. PubMed ID: 36828585
    [Abstract] [Full Text] [Related]

  • 5. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 02; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 6. Early referral of patients with suspected polymyalgia rheumatica - A systematic review.
    Nielsen AW, Hemmig AK, de Thurah A, Schmidt WA, Sattui SE, Mackie SL, Brouwer E, Dejaco C, Keller KK, Mukhtyar CB.
    Semin Arthritis Rheum; 2023 Dec 02; 63():152260. PubMed ID: 37639896
    [Abstract] [Full Text] [Related]

  • 7. Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.
    Keller KK, Mukhtyar CB, Nielsen AW, Hemmig AK, Mackie SL, Sattui SE, Hauge EM, Dua A, Helliwell T, Neill L, Blockmans D, Devauchelle-Pensec V, Hayes E, Venneboer AJ, Monti S, Ponte C, De Miguel E, Matza M, Warrington KJ, Byram K, Yaseen K, Peoples C, Putman M, Lally L, Finikiotis M, Appenzeller S, Caramori U, Toro-Gutiérrez CE, Backhouse E, Oviedo MCG, Pimentel-Quiroz VR, Keen HI, Owen CE, Daikeler T, de Thurah A, Schmidt WA, Brouwer E, Dejaco C.
    Ann Rheum Dis; 2024 Oct 21; 83(11):1436-1442. PubMed ID: 38050004
    [Abstract] [Full Text] [Related]

  • 8. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D.
    Semin Arthritis Rheum; 2024 Oct 21; 68():152499. PubMed ID: 38968729
    [Abstract] [Full Text] [Related]

  • 9. Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets.
    Nepal D, Putman M, Unizony S.
    Rheum Dis Clin North Am; 2023 Aug 21; 49(3):505-521. PubMed ID: 37331730
    [Abstract] [Full Text] [Related]

  • 10. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

  • 11. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH.
    Prim Care; 2018 Jun 15; 45(2):305-323. PubMed ID: 29759126
    [Abstract] [Full Text] [Related]

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 13. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA, Pina T.
    Curr Rheumatol Rep; 2015 Feb 01; 17(2):6. PubMed ID: 25618572
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL, Buttgereit F, Dejaco C, Dasgupta B.
    Rheum Dis Clin North Am; 2016 Feb 01; 42(1):75-90, viii. PubMed ID: 26611552
    [Abstract] [Full Text] [Related]

  • 15. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I, Arends S, Dalsgaard Nielsen B, Therkildsen P, Hansen I, van 't Ende A, Heeringa P, Boots A, Hauge E, Brouwer E, van Sleen Y.
    RMD Open; 2023 Jan 01; 9(1):. PubMed ID: 36631159
    [Abstract] [Full Text] [Related]

  • 16. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):2764-2773. PubMed ID: 32031663
    [Abstract] [Full Text] [Related]

  • 17. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.
    J Rheumatol; 2009 Oct 01; 36(10):2269-76. PubMed ID: 19684157
    [Abstract] [Full Text] [Related]

  • 18. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M, Pope JE.
    Best Pract Res Clin Rheumatol; 2022 Dec 01; 36(4):101822. PubMed ID: 36907732
    [Abstract] [Full Text] [Related]

  • 19. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec 01; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 20. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M.
    Praxis (Bern 1994); 2020 Dec 01; 109(5):347-354. PubMed ID: 32233763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.